Recent articles
Here's Why Amyris Is Soaring Today
The industrial biotech has punched its ticket to the cannabis party, but investors shouldn't get too excited just yet.
3 Things to Watch at Cameco in 2019
The uranium miner and fuel fabricator has battened down the hatches to weather dismal market fundamentals in recent years. Is this the year the efforts pay off?
3 Things to Watch With Ballard Power Systems in 2019
Shares of the fuel cell manufacturer have gained almost 50% so far in 2019, but a continued rise isn't quite a certainty.
Here's Why Corcept Therapeutics Fell as Much as 13.7% Today
The company announced preliminary full-year 2018 results that fell below Wall Street's expectations.
Is Aurinia Pharmaceuticals a Buy?
The pharma company bounced around for much of 2018, but there's intriguing potential in the pipeline.
Don't Waste Your Money on Penny Stocks. These 3 Stocks Are Better Buys
Long-term investing is a solid way to build wealth. Penny stocks? Not so much.
Here's Why Voyager Therapeutics Stock Soared as Much as 62.9% Today
The company just licensed four drug programs for a cool $165 million up-front payment -- with the potential to receive $1.7 billion in future milestone payments.
Here's Why Versum Materials Soared Higher Today
The basic materials company has agreed to merge with a competitor to create a $9 billion behemoth.
Here's Why Vale SA Stock Plummeted Today
A dam owned by the company collapsed in Brazil, leaving over 60 people dead and nearly 300 missing.
1 Surprising Obstacle to Reaching America's Climate Change Goals
A quirky financial accounting rule is helping to keep America's coal-fired power plants open.
Is Rigel Pharmaceuticals a Buy?
This small-cap stock had a rough 2018, but the company just launched its first drug product. Will it be enough to regain Wall Street's trust?
3 Things SolarEdge Technologies Investors Should Watch in 2019
The company cemented its leadership position in the solar market and grew hand over fist last year. It wasn't enough for Wall Street. Will that change this year?
Here's Why Corcept Therapeutics Stock Fell as Much as 18.5% Today
An investigative report is shining light on some very serious questions about the company. Shareholders absolutely must read it.
Here's Why Urogen Pharma Fell as Much as 12.4% Today
The pharma company announced the pricing of a share offering, but the cash will help to launch a promising new drug for cancer patients.
Is Cara Therapeutics a Buy?
The $600 million pharma company is working on a drug with estimated peak annual sales of $500 million.
3 Things to Watch for FMC Corporation in 2019
After March 1, the company will be solely focused on agricultural sciences. It'll need to get to work quickly to shore up its pipeline.
Here's Why PTC Therapeutics Fell as Much as 11.7% Today
The company announced the pricing of a share offering announced the day before.
3 Things to Watch for Alcoa in 2019
The industrial powerhouse expects the aluminum market to grow at its slowest pace since the Great Recession. What will that mean for the business?
3 Things for Albemarle Investors to Watch in 2019
The world's premier lithium producer is struggling to convince Wall Street of its growth potential, but investors can watch for these signs of progress.
3 Top Growth Stocks to Buy Right Now
Start the year off the right way by injecting some long-term growth potential into your portfolio with one (or all) of these stocks.